Clinical Trial Update: A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients [Phase 3]

View source ↗

Summary

Phase 3 trial results have been posted for intravenous Mircera in the treatment of anemia in dialysis patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia of Chronic Kidney Disease
• End-stage Renal Disease

Drugs mentioned

• MIRCERA (METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Anemia | Phase 3 | Status: COMPLETED | Results posted: 2016-02-29